Skip to main content
Top
Published in: Diabetologia 6/2008

01-06-2008 | Letter

Diabetic podopathy—yes please! Reply to Boulton AJM, Armstrong DG, Baker NR et al. [letter]

Author: W. Jeffcoate

Published in: Diabetologia | Issue 6/2008

Login to get access

Excerpt

To the Editor: If we all had the same opinions, the world would be a dull place. And while differences serve to stimulate debate, it is nevertheless fortunate that we do agree about most things. Thus, I and A. J. M. Boulton and colleagues all agree that interest in disease of the foot is increasing fast, with new multi-disciplinary clinics opening up around the world [1]. This interest has been associated with a steady increase in scientific publications in the field (many of which are the product of their own enormous efforts) and a gratifying increase in academic meetings dedicated to it. We agree that many different professional groups contribute to this improvement in care, with podiatrists and nurses being foremost among them. We agree that we are striving to ensure that foot disease attracts attention commensurate with the suffering that it causes. …
Metadata
Title
Diabetic podopathy—yes please! Reply to Boulton AJM, Armstrong DG, Baker NR et al. [letter]
Author
W. Jeffcoate
Publication date
01-06-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 6/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-0977-0

Other articles of this Issue 6/2008

Diabetologia 6/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.